Raymond James Financial Services Advisors’s Ascendis Pharma ASND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-8,224
| Closed | -$1.04M | – | 3380 |
|
|
2023
Q4 | $1.04M | Sell |
8,224
-6,766
| -45% | -$852K | ﹤0.01% | 1957 |
|
|
2023
Q3 | $1.4M | Buy |
14,990
+5,229
| +54% | +$490K | ﹤0.01% | 1717 |
|
|
2023
Q2 | $871K | Buy |
9,761
+1,593
| +20% | +$142K | ﹤0.01% | 2003 |
|
|
2023
Q1 | $876K | Buy |
8,168
+2,701
| +49% | +$290K | ﹤0.01% | 1991 |
|
|
2022
Q4 | $668K | Buy |
+5,467
| New | +$668K | ﹤0.01% | 2100 |
|